- Home
- APGE vs AIR Comparison
APGE vs AIR Comparison
Compare APGE & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- AIR
- Stock Information
- Founded
- APGE 2022
- AIR 1951
- Country
- APGE United States
- AIR United States
- Employees
- APGE N/A
- AIR N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- AIR Aerospace
- Sector
- APGE Health Care
- AIR Industrials
- Exchange
- APGE Nasdaq
- AIR Nasdaq
- Market Cap
- APGE 2.3B
- AIR 2.3B
- IPO Year
- APGE 2023
- AIR 1988
- Fundamental
- Price
- APGE $34.55
- AIR $61.81
- Analyst Decision
- APGE Strong Buy
- AIR Strong Buy
- Analyst Count
- APGE 5
- AIR 4
- Target Price
- APGE $83.50
- AIR $81.50
- AVG Volume (30 Days)
- APGE 514.4K
- AIR 173.3K
- Earning Date
- APGE 03-04-2025
- AIR 03-20-2025
- Dividend Yield
- APGE N/A
- AIR N/A
- EPS Growth
- APGE N/A
- AIR N/A
- EPS
- APGE N/A
- AIR 0.28
- Revenue
- APGE N/A
- AIR $2,571,600,000.00
- Revenue This Year
- APGE N/A
- AIR $19.84
- Revenue Next Year
- APGE N/A
- AIR $6.37
- P/E Ratio
- APGE N/A
- AIR $217.64
- Revenue Growth
- APGE N/A
- AIR 18.53
- 52 Week Low
- APGE $32.46
- AIR $54.71
- 52 Week High
- APGE $72.29
- AIR $76.34
- Technical
- Relative Strength Index (RSI)
- APGE 35.39
- AIR 30.31
- Support Level
- APGE $32.46
- AIR $64.36
- Resistance Level
- APGE $37.42
- AIR $65.42
- Average True Range (ATR)
- APGE 2.17
- AIR 1.63
- MACD
- APGE -0.30
- AIR -0.75
- Stochastic Oscillator
- APGE 20.84
- AIR 0.88
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.